US Pharma MarketingThe post Thermo Fisher raises 2026 outlook after 10% growth in Q2 appeared first on Medical Device Network.
Thermo Fisher raises 2026 outlook after 10% growth in Q2
Thermo’s Q2 performance was driven by its laboratory products and biopharma services business with profits around $6.69bn equating to a 12% uptick YoY. The post Thermo Fisher raises 2026 outlook after 10% growth in Q2 appeared first on Medical Device Network .
Thermo’s Q2 performance was driven by its laboratory products and biopharma services business with profits around $6.69bn equating to a 12% uptick YoY.
Source: Medical Device Network